Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years
The Journal of Physiology · 2024
DOI: 10.1113/jp287069 ↗At a glance
Beobachtungsstudie in The Journal of Physiology, 2024. Written by William J Evans and 15 co-authors. Institution: Department Nutritional Sciences and Toxicology, University of California, Berkeley, California, USA. Major MEDLINE topics: Muscular Dystrophy, Duchenne, Muscle, Skeletal, Walking. Cited 7 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: Muscular Dystrophy Association (MDA), Parent Project Muscular Dystrophy (PPMD), Duchenne UK.
Abstract (original language)
Duchenne muscular dystrophy (DMD) results in a progressive loss of functional skeletal muscle mass (MM) and replacement with fibrofatty tissue. Accurate evaluation of MM in DMD patients has not previously been available. Our objective was to measure MM using the D 3 creatine (D 3 Cr) dilution method and determine its relationship with strength and functional capacity in patients with DMD over a wide range of ages. Subjects were recruited for participation in a 12 month, longitudinal, observational study. Here, we report the baseline data. A 20 mg dose of D 3 Cr dissolved in water was ingested by 92 patients with DMD (ages 4–25 years) followed later with a fasting urine sample. Enrichment of D 3 creatinine was determined by liquid chromatography‐mass spectrometry analysis. The North Star Ambulatory Assessment (NSAA) total score was determined for ambulatory participants, and the Performance of Upper Limb (PUL 2.0) total score and grip strength for all participants. We observed a significant age‐associated increase in body weight along with a substantial decrease in MM/body weight (%MM). MM and %MM were associated with PUL score ( r = 0.517, P < 0.0001 and r = 0.764, P < 0.0001 respectively). The age‐associated decrease in MM and %MM was strongly associated with ambulatory status. We observed very little overlap in %MM between ambulant and non‐ambulant subjects, suggesting a threshold of 18–22% associated with loss of ambulation. MM is substantially diminished with advancing age and is highly related to clinically meaningful functional status. The D 3 Cr dilution method may provide a biomarker of disease progression and therapeutic efficacy in patients with DMD or other neuromuscular disorders. image Key points The non‐invasive D 3 creatine dilution method provides novel data on whole body functional muscle mass (MM) in a wide range of ages in patients with DMD and reveals profoundly low functional MM in older non‐ambulant patients. The difference in %MM between ambulant and non‐ambulant subjects suggests a threshold for loss of ambulatory ability between 18 and 22% MM. The data suggest that as functional MM declines with age, maintaining a lower body weight may help to conserve ambulatory ability.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department Nutritional Sciences and Toxicology, University of California, Berkeley, California, USA.
- Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
- Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
- John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
ORCID profiles: William J Evans, Marc Hellerstein, Edward Smith, Michela Guglieri, Meredith K James, Tyler Field, Mahalakshmi Shankaran
Funding
- Muscular Dystrophy Association (MDA)
- Parent Project Muscular Dystrophy (PPMD)
- Duchenne UK
Cite
APA
Evans, W. J., Hellerstein, M., Butterfield, R. J., Smith, E., Guglieri, M., Katz, N., Nave, B., Branigan, L., Thera, S., Vordos, K. L., Behar, L., Schiava, M., James, M. K., Field, T., Mohammed, H., & Shankaran, M. (2024). Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years. The Journal of Physiology. https://doi.org/10.1113/jp287069
Vancouver
Evans WJ, Hellerstein M, Butterfield RJ, Smith E, Guglieri M, Katz N, et al. Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years. The Journal of Physiology. 2024. doi:10.1113/jp287069
BibTeX
@article{Evans2024,
author = {Evans, William J and Hellerstein, Marc and Butterfield, Russell J and Smith, Edward and Guglieri, Michela and Katz, Natalie and Nave, Brittany and Branigan, Lauren and Thera, Stephanie and Vordos, Kalista L and Behar, Laura and Schiava, Marianela and James, Meredith K and Field, Tyler and Mohammed, Hussein and Shankaran, Mahalakshmi},
title = {Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years},
journal = {The Journal of Physiology},
year = {2024},
doi = {10.1113/jp287069}
}
EUVIMED